InChI=1S/C26H23F2N3O4/c1- 14(29- 25(34) 23(32) 15- 11- 16(27) 13- 17(28) 12- 15) 24(33) 30- 22- 20- 9- 4- 3- 7- 18(20) 19- 8- 5- 6- 10- 21(19) 31(2) 26(22) 35/h3- 14,22- 23,32H,1- 2H3,(H,29,34) (H,30,33) /t14- ,22- ,23- /m0/s1 |
ULSSJYNJIZWPSB-CVRXJBIPSA-N |
C[C@H](NC(=O)[C@@H](O)c1cc(F)cc(F)c1)C(=O)N[C@H]1c2ccccc2-c2ccccc2N(C)C1=O |
|
EC 3.4.23.46 (memapsin 2) inhibitor
An EC 3.4.23.* (aspartic endopeptidase) inhibitor that interferes with the activity of memapsin 2 (EC 3.4.23.46).
|
|
View more via ChEBI Ontology
N2- [(2S)- 2- (3,5- difluorophenyl)- 2- hydroxyacetyl]- N- [(7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo[b,d]azepin- 7- yl]- L- alaninamide
|
LSN-411575
|
ChEBI
|
LY-411575
|
SUBMITTER
|
LY411575
|
ChEBI
|
N2- [(2S)- 2- (3,5- difluorophenyl)- 2- hydroxyethanoyl]- N1- [(7S)- 5- methyl- 6- oxo- 6,7- dihydro- 5H- dibenzo[b,d]azepin- 7- yl]- L- alaninamide
|
ChEBI
|
10736555
|
Reaxys Registry Number
|
Reaxys
|
209984-57-6
|
CAS Registry Number
|
SUBMITTER
|
McAlarney T, Ogino M, Apostolski S, Latov N (1995) Specificity and cross-reactivity of anti-galactocerebroside antibodies. Immunological investigations 24, 595-606 [PubMed:7542630] [show Abstract] Anti-galactocerebroside (GalC) antibodies have been reported to inhibit myelin formation, cause demyelination, and block HIV-I infection of neural cells. We examined the binding of 3 monoclonal and polyclonal anti-GalC antibodies to a panel of purified glycolipids by ELISA and by an immunospot assay on nitrocellulose blots. All 3 antibodies bound strongly to GM1 ganglioside, monogalactosyl diglyceride, and asialo-GM1, and 2 of the antibodies bound to GD1b and psychosine. The anti-GalC antibodies also bound to 3 glycoprotein bands in human neuroblastoma cells on Western blot, and binding to the proteins was abolished by pre-treatment with pronase or with periodate which oxidizes the terminal carbohydrate residues. These results indicate that anti-GalC antibodies cross react with oligosaccharide determinants of other glycolipids and glycoproteins, and that these cross-reactivities may be responsible for some of the biological effects of the anti-GalC antibodies. |
|